hydroxychloroquine

How CMC Vellore Dealt With Shifting Evidence During the COVID-19 Pandemic

India COVID-19 Response Suggests ‘Scientific Superpower’ Tag an Impossible Dream

Four Months After Itolizumab ‘Trial’ and 9 Million Infections Later – No Progress

A Brief History of How the Trump Administration Eroded Trust in the FDA

Is Favipiravir Good for COVID-19? Clinical Trial Says No, Press Release Says Yes

COVID-19: Remdesivir Caught in Storm After Poor WHO Trial Results and EU Deal

COVID-19: Donald Trump Receives Experimental Antibody Cocktail Treatment

COVID-19: Centre Admits It Has No Data on Usage Pattern of HCQ by Health Workers

Where in India’s COVID-19 Response Is the Moral Compass That Guides Governance?

‘Failed to Reduce Mortality’: WHO to Discontinue Hydroxychloroquine Trials